Amneal Pharmaceuticals, Inc.
AMRX
$12.60
-$0.18-1.41%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 62.26M | 35.08M | 2.37M | 22.42M | 12.20M |
| Total Depreciation and Amortization | 43.19M | 49.23M | 54.07M | 60.11M | 60.16M |
| Total Amortization of Deferred Charges | 3.89M | 3.72M | 5.03M | 6.88M | 6.81M |
| Total Other Non-Cash Items | 54.00M | 54.59M | 107.72M | 29.52M | 34.62M |
| Change in Net Operating Assets | -190.08M | -12.29M | -50.74M | -35.11M | -106.38M |
| Cash from Operations | -26.74M | 130.32M | 118.45M | 83.82M | 7.41M |
| Capital Expenditure | -13.86M | -43.17M | -15.05M | -26.50M | -14.12M |
| Sale of Property, Plant, and Equipment | -- | 715.00K | 0.00 | 855.00K | 524.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -7.85M | -3.00M | -7.41M | -900.00K | -4.20M |
| Cash from Investing | -21.71M | -45.45M | -22.46M | -26.55M | -17.80M |
| Total Debt Issued | 135.18M | 795.00K | 2.70B | 0.00 | 218.00M |
| Total Debt Repaid | -140.84M | -6.12M | -2.55B | -15.55M | -235.53M |
| Issuance of Common Stock | 38.00K | 553.00K | 653.00K | 685.00K | 69.00K |
| Repurchase of Common Stock | -44.31M | -321.00K | -129.00K | -189.00K | -21.64M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -9.13M | -5.02M | -87.10M | -26.64M | -68.00K |
| Cash from Financing | -59.06M | -10.12M | 59.44M | -41.69M | -39.17M |
| Foreign Exchange rate Adjustments | -1.02M | -209.00K | -694.00K | -307.00K | -470.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -108.53M | 74.53M | 154.74M | 15.28M | -50.03M |